[Synthetic progestins in combined treatment of cancer of the uterine body].
The effect of 17-hydroxyprogesterone-capronate therapy on primary tumor in 102 patients with cancer of the uterine body in 1-11 stage was studied. A more pronounced therapeutic effect of the hormone therapy was noted in patients with a high degree of differentiation and less tumor mass.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000627:therapeutic use*; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy*
D006908:Hydroxyprogesterones
Sinteticheskie progestiny v kombinirovannon lechenii raka tela matki